Missing the @AACR #PancreaticCancer meeting this year, but the past & present Maitra Lab presence is strong in San Diego. Proud of these guys! @FredrikThege @PeterYuMD @Vince_BernPag #AACRPanCa2026

Dr. @PeterYuMD @nyulangone presents KRAS ctDNA monitoring in patients receiving daraxonrasib, with a 45% reported RAS ctDNA clearance rate and NYU cohort data showing KRAS ctDNA was detected in 60% at baseline and 40% clearance on follow-up. The key question: Does early KRAS ctDNA clearance on daraxonrasib associate with clinical efficacy, including ORR and PFS? #DAVAGI #BermudaGI2026

Pulling out all the stops vs pancreatic cancer. The recent FDA-approved, celebrated drug daraxonrasib, increased median survival by 6.5 months @RevMedicines That's a positive step but clearly not enough. This new @Cancer_Cell paper lays out a path for more. cell.com/cancer-cell/fulltex…

Congratulations to @Perlmutter_CC physician scientist @PeterYuMD on submitting his K08 grant on novel resistance mechanisms to KRAS inhibitors in #PancreaticCancer. Now it’s 🍪 time!

It would be awesome to co-run a lab with another PI. I feel like there’s a lot of growth potential

Grateful for the opportunity to give a lightning presentation at #AACRpac23! Thank you to the organizers, as well as #AlecKimmelman and Kimmelman lab, @SAAswim, @NYUGSOM_HemeOnc, #perlmutter cancer center

Congratulations genitourinary oncology chief fellow Dr. Minas Economides of @NYUGSOM_HemeOnc @nyugrossman! #ASCO23 @ASCO

Congrats to Mohammad Assi from the Kimmelman lab for this great review! ⁦@NatureCancer⁩ #autophagy nature.com/articles/s43018-0…

1/ Grant-writing tips. This #tweetorial mainly applies to @NIH grants (particularly R01s) but some stuff may be applicable to other types of grants and funding agencies. Based on my experience writing grants for 20 yrs +lots of cringe-worthy missteps and rejections along the way!

Kudos to Dr. Alec Kimmelman on a $1.7 million Drug Discovery Award from @TheMarkFdn. He & Dr. Seth Parker @UBC will work to ID molecules that inhibit the amino acid transporter SLC38A2, a novel target for #pancreaticcancer @nyugrossman @NYULH_RadOnc bit.ly/3jELZL9

32 resources for (to-be) faculty on salary negotiation, grant writing, funding, and lab management. A thread 🧵 👇

Thanks to Liz, @ConquerCancerFd, @SAAswim, and my mentor Alec Kimmelman for this Young Investigator Award. Working hard so we can improve outcomes for patients like Ted.